RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit
PR Newswire —
NEW YORK, Feb. 16, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the "Class Period"). A class action...